Having a child with vs. without cystic fibrosis heightened the odds for job lock and curtailed employment among parents/caregivers, according to a research letter published in JAMA Pediatrics.“U.S.
Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...
An Indianapolis family, after successfully navigating their second-born's battle with Cystic Fibrosis, is determined to help other expecting families learn about a newer therapy option.
Despite the existence of numerous clinical practice guidelines (CPGs) for cystic fibrosis (CF), there is limited understanding of their credibility and consistency. This systematic review aims to ...
The management of CF has been changing drastically over the last few years, especially after the introduction of CFTR modulators. Currently, 188,336 people have the disease in 96 countries, but only ...
Skin fibrosis is an often-painful condition wherein the skin thickens and hardens, making it difficult to move. And with no effective treatments currently available, patients are left with few avenues ...
Louise Patterson, from Bray, is the mother of Aaron, who will soon be 12. His rare gene means he is currently excluded from modulator therapy Kaftrio, which, when combined with other medication ...
Several years ago, my dad was diagnosed with pulmonary fibrosis. The news was a shock. At 84 years old, Daddy had been dedicated to his physical health for decades. He played tennis twice a week, ate ...
Woman with cystic fibrosis to embark on 3,200 mile row across Atlantic Ocean in historic world-first
Sophie out on the boat ahead of her pioneering rowing journey with cystic fibrosis (Supplied) Therapy sessions were offered as part of her cystic fibrosis treatment at Cardiff. At first ...
What I’ve since come to learn, especially now that I report on mental health, is that therapy can be helpful and even life-changing. But its success largely depends on your relationship with ...
Please provide your email address to receive an email when new articles are posted on . Researchers deemed 24-week vanzacaftor/tezacaftor/deutivacaftor safe in 6- to ...
University of South Florida pulmonologist Dr. Jose Herazo-Maya has focused his career on researching treatments for pulmonary fibrosis, a devastating and deadly lung disease. Pulmonary fibrosis in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results